Erydel
Red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€91m (Public information from Feb 2020)
Bresso Lombardy (HQ)
Authorizing premium user...